ASXL1 Directs Neutrophilic Differentiation via Modulation of MYC and RNA Polymerase II
Authors:
- Theodore P. BraunTBTheodore P. Braun
- Joseph EstabrookJEJoseph Estabrook
- Lucie DarmuseyLDLucie Darmusey
- Daniel J. ColemanDCDaniel J. Coleman
- Zachary SchonrockZSZachary Schonrock
- Brittany M. SmithBSBrittany M. Smith
- Akram TaherinasabATAkram Taherinasab
- Trevor EnrightTETrevor Enright
- Cody CoblentzCCCody Coblentz
- William YasharWYWilliam Yashar
- Hisham MohammedHMHisham Mohammed
Preprint
Abstract
Mutations in the gene Additional Sex-Combs Like 1 (ASXL1) are recurrent in myeloid malignancies as well as the pre-malignant condition clonal hematopoiesis, where they are universally associated with poor prognosis. An epigenetic regulator, ASXL1 canonically directs the deposition of H3K27me3 via the polycomb repressive complex 2. However, its precise role in myeloid lineage maturation is incompletely described. We utilized single cell RNA sequencing (scRNA-seq) on a murine model of hematopoietic-specific ASXL1 deletion and identified a specific role for ASXL1 in terminal granulocyte maturation. Terminal maturation is accompanied by down regulation of Myc expression and cell cycle exit. ASXL1 deletion leads to hyperactivation of Myc in granulocyte precursors and a quantitative decrease in neutrophil production. This failure of normal developmentallyassociated Myc suppression is not accompanied by significant changes in the landscape of covalent histone modifications including H3K27me3. Examining the genome-wide localization of ASXL1 in myeloid progenitors revealed strong co-localization with RNA Polymerase II (RNAPII) at the promoters and spread across the gene bodies of transcriptionally active genes. ASXL1 deletion results in a decrease in RNAPII promoter-proximal pausing in granulocyte progenitors, indicative of a global increase in productive transcription, consistent with the known role of ASXL1 as a mediator of RNAPII pause release. These results suggest that ASXL1 inhibits productive transcription in granulocyte progenitors, identifying a new role for this epigenetic regulator and highlighting a novel potential oncogenic mechanism for ASXL1 mutations in myeloid malignancies.Keywords
This publication has 55 references indexed in Scilit:
- Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutationsJournal of Clinical Investigation, 2013
- The Subread aligner: fast, accurate and scalable read mapping by seed-and-voteNucleic Acids Research, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseasesJournal of Hematology & Oncology, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Differential oestrogen receptor binding is associated with clinical outcome in breast cancerNature, 2012
- Neutrophil kinetics in health and diseaseTrends in Immunology, 2010
- BEDTools: a flexible suite of utilities for comparing genomic featuresBioinformatics, 2010
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Elucidation of the Phenotypic, Functional, and Molecular Topography of a Myeloerythroid Progenitor Cell HierarchyCell Stem Cell, 2007